| Year |
Citation |
Score |
| 2017 |
Glasner-Edwards S, Mooney LJ, Ang A, Garneau HC, Hartwell E, Brecht ML, Rawson RA. Mindfulness Based Relapse Prevention for Stimulant Dependent Adults: A Pilot Randomized Clinical Trial. Mindfulness. 8: 126-135. PMID 28191264 DOI: 10.1007/S12671-016-0586-9 |
0.348 |
|
| 2017 |
Gonzales R, Steinberg J, Winters KC, Murphy DA, Ang A, Hernandez M, Mugahwi M. Examining Treatment Outcomes: Differences Between Primary and Non-Primary Marijuana-Using Youths Transitioning Into Recovery Journal of Child & Adolescent Substance Abuse. 26: 265-276. DOI: 10.1080/1067828X.2017.1305929 |
0.367 |
|
| 2016 |
Cousins SJ, Radfar SR, Crèvecoeur-MacPhail D, Ang A, Darfler K, Rawson RA. Predictors of Continued Use of Extended-Released Naltrexone (XR-NTX) for Opioid-Dependence: An Analysis of Heroin and Non-Heroin Opioid Users in Los Angeles County. Journal of Substance Abuse Treatment. 63: 66-71. PMID 26823295 DOI: 10.1016/J.Jsat.2015.12.004 |
0.315 |
|
| 2016 |
Gonzales R, Hernandez M, Murphy DA, Ang A. Youth recovery outcomes at 6 and 9 months following participation in a mobile texting recovery support aftercare pilot study. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 25: 62-8. PMID 26689171 DOI: 10.1111/Ajad.12322 |
0.305 |
|
| 2015 |
Nosyk B, Bray JW, Wittenberg E, Aden B, Eggman AA, Weiss RD, Potter J, Ang A, Hser YI, Ling W, Schackman BR. Short term health-related quality of life improvement during opioid agonist treatment. Drug and Alcohol Dependence. PMID 26511766 DOI: 10.1016/J.Drugalcdep.2015.10.009 |
0.309 |
|
| 2015 |
Jacobs P, Ang A, Hillhouse MP, Saxon AJ, Nielsen S, Wakim PG, Mai BE, Mooney LJ, S Potter J, Blaine JD. Treatment outcomes in opioid dependent patients with different buprenorphine/naloxone induction dosing patterns and trajectories. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 24: 667-75. PMID 26400835 DOI: 10.1111/Ajad.12288 |
0.314 |
|
| 2015 |
Barnes AJ, Xu H, Tseng CH, Ang A, Tallen L, Moore AA, Marshall DC, Mirkin M, Ransohoff K, Duru OK, Ettner SL. The effect of a patient-provider educational intervention to reduce at-risk drinking on changes in health and health-related quality of life among older adults: the Project SHARE study. Journal of Substance Abuse Treatment. PMID 26254687 DOI: 10.1016/J.Jsat.2015.06.019 |
0.316 |
|
| 2015 |
Haglund M, Ang A, Mooney L, Gonzales R, Chudzynski J, Cooper CB, Dolezal BA, Gitlin M, Rawson RA. Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 24: 246-51. PMID 25907813 DOI: 10.1111/Ajad.12175 |
0.303 |
|
| 2015 |
Nielsen S, Hillhouse M, Mooney L, Ang A, Ling W. Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users. Journal of Substance Abuse Treatment. 48: 70-6. PMID 25065489 DOI: 10.1016/J.Jsat.2014.06.006 |
0.305 |
|
| 2015 |
Hillhouse MP, Ang A, Thomas C, Nielsen S, Walker R, Potter J, Brigham G, Stout S, Weimer M, Winhusen T. Opioid use severity and treatment outcomes in cocaine-dependent participants with a history of opioid abuse/dependence Drug and Alcohol Dependence. 156. DOI: 10.1016/J.Drugalcdep.2015.07.1176 |
0.323 |
|
| 2015 |
Mooney L, Hillhouse MP, Ang A, Jenkins J, Ling W. Methamphetamine dependence, psychiatric disorders, and treatment outcomes in individuals treated with methylphenidate Drug and Alcohol Dependence. 146. DOI: 10.1016/J.Drugalcdep.2014.09.492 |
0.306 |
|
| 2014 |
Ling W, Chang L, Hillhouse M, Ang A, Striebel J, Jenkins J, Hernandez J, Olaer M, Mooney L, Reed S, Fukaya E, Kogachi S, Alicata D, Holmes N, Esagoff A. Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder. Addiction (Abingdon, England). 109: 1489-500. PMID 24825486 DOI: 10.1111/Add.12608 |
0.304 |
|
| 2014 |
Gonzales R, Ang A, Murphy DA, Glik DC, Anglin MD. Substance use recovery outcomes among a cohort of youth participating in a mobile-based texting aftercare pilot program Journal of Substance Abuse Treatment. 47: 20-26. PMID 24629885 DOI: 10.1016/J.Jsat.2014.01.010 |
0.326 |
|
| 2014 |
Rawson R, Chudzynski J, Gonzales-Castaneda R, Ang A. Differences in mood and quality of life indicators by HIV status in a group of methamphetamine-dependent individuals Drug and Alcohol Dependence. 140. DOI: 10.1016/J.Drugalcdep.2014.02.513 |
0.354 |
|
| 2014 |
Mooney L, Hillhouse MP, Ang A, Miotto K, Torrington M, Dickerson D, MacNicoll S, Jenkins J, Reed S, Ling W. Psychiatric diagnoses and treatment outcomes in opioid-dependent individuals receiving buprenorphine and behavioral treatment Drug and Alcohol Dependence. 140. DOI: 10.1016/J.Drugalcdep.2014.02.438 |
0.325 |
|
| 2013 |
Glasner-Edwards S, Mooney LJ, Ang A, Hillhouse M, Rawson R. Does Posttraumatic Stress Disorder (PTSD) Affect Post-Treatment Methamphetamine Use? Journal of Dual Diagnosis. 9: 123-128. PMID 24065875 DOI: 10.1080/15504263.2013.779157 |
0.317 |
|
| 2013 |
Potter JS, Marino EN, Hillhouse MP, Nielsen S, Wiest K, Canamar CP, Martin JA, Ang A, Baker R, Saxon AJ, Ling W. Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). Journal of Studies On Alcohol and Drugs. 74: 605-13. PMID 23739025 DOI: 10.15288/Jsad.2013.74.605 |
0.333 |
|
| 2013 |
Ling W, Hillhouse M, Ang A, Jenkins J, Fahey J. Comparison of behavioral treatment conditions in buprenorphine maintenance. Addiction (Abingdon, England). 108: 1788-98. PMID 23734858 DOI: 10.1111/Add.12266 |
0.311 |
|
| 2013 |
Crist RC, Clarke TK, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH. An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2003-10. PMID 23612435 DOI: 10.1038/Npp.2013.99 |
0.314 |
|
| 2011 |
Gonzales R, Ang A, Glik DC, Rawson RA, Lee S, Iguchi MY. Quality of life among treatment seeking methamphetamine-dependent individuals. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 20: 366-72. PMID 21679268 DOI: 10.1111/J.1521-0391.2011.00142.X |
0.355 |
|
| 2011 |
Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R. Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment. Eating Disorders. 19: 259-69. PMID 21516550 DOI: 10.1080/10640266.2011.566149 |
0.349 |
|
| 2010 |
Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R. Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 19: 385-90. PMID 20716300 DOI: 10.1111/J.1521-0391.2010.00061.X |
0.344 |
|
| 2010 |
Conover CJ, Weaver M, Arno P, Ang A, Ettner SL. Insurance coverage among people living with combined HIV/AIDS, chronic mental illness, and substance abuse disorders. Journal of Health Care For the Poor and Underserved. 21: 1006-30. PMID 20693741 DOI: 10.1353/Hpu.0.0330 |
0.317 |
|
| 2010 |
Interian A, Ang A, Gara MA, Link BG, Rodriguez MA, Vega WA. Stigma and depression treatment utilization among Latinos: utility of four stigma measures. Psychiatric Services (Washington, D.C.). 61: 373-9. PMID 20360276 DOI: 10.1176/Ps.2010.61.4.373 |
0.323 |
|
| 2010 |
Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson RA. Psychopathology in methamphetamine-dependent adults 3 years after treatment. Drug and Alcohol Review. 29: 12-20. PMID 20078677 DOI: 10.1111/J.1465-3362.2009.00081.X |
0.34 |
|
| 2009 |
Conover CJ, Weaver M, Ang A, Arno P, Flynn PM, Ettner SL. Costs of care for people living with combined HIV/AIDS, chronic mental illness, and substance abuse disorders. Aids Care. 21: 1547-59. PMID 20024734 DOI: 10.1080/09540120902923006 |
0.329 |
|
| 2009 |
Gonzales R, Ang A, Marinelli-Casey P, Glik DC, Iguchi MY, Rawson RA. Health-related quality of life trajectories of methamphetamine-dependent individuals as a function of treatment completion and continued care over a 1-year period. Journal of Substance Abuse Treatment. 37: 353-61. PMID 19553066 DOI: 10.1016/J.Jsat.2009.04.001 |
0.328 |
|
| 2009 |
Glasner-Edwards S, Marinelli-Casey P, Hillhouse M, Ang A, Mooney LJ, Rawson R. Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up. The Journal of Nervous and Mental Disease. 197: 225-31. PMID 19363377 DOI: 10.1097/Nmd.0B013E31819Db6Fe |
0.311 |
|
| 2008 |
Gonzales R, Ang A, McCann MJ, Rawson RA. An emerging problem: methamphetamine abuse among treatment seeking youth. Substance Abuse. 29: 71-80. PMID 19042326 DOI: 10.1080/08897070802093312 |
0.339 |
|
| 2008 |
Ettner SL, Conover CJ, Proescholdbell RJ, Weaver MR, Ang A, Arno PS. Triply-diagnosed patients in the HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study: patterns of home care use. Aids Care. 20: 1177-89. PMID 18608077 DOI: 10.1080/09540120801918644 |
0.306 |
|
| 2008 |
Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R, Anglin MD, Balabis J, Bradway R, Brown AH, Burke C, Christian D, Cohen J, Cosmineanu F, Dickow A, et al. Identifying methamphetamine users at risk for major depressive disorder: Findings from the methamphetamine treatment project at three-year follow-up American Journal On Addictions. 17: 99-102. PMID 18393051 DOI: 10.1080/10550490701861110 |
0.321 |
|
| 2008 |
Rawson RA, Gonzales R, Pearce V, Ang A, Marinelli-Casey P, Brummer J. Methamphetamine dependence and human immunodeficiency virus risk behavior. Journal of Substance Abuse Treatment. 35: 279-84. PMID 18329225 DOI: 10.1016/J.Jsat.2007.11.003 |
0.317 |
|
| 2008 |
Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R, Anglin MD, Balabis J, Bradway R, Brown AH, Burke C, Christian D, Cohen J, Cosmineanu F, Dickow A, et al. Risk factors for suicide attempts in methamphetamine-dependent patients American Journal On Addictions. 17: 24-27. PMID 18214719 DOI: 10.1080/10550490701756070 |
0.348 |
|
| 2008 |
Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Ettner SL. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders. Journal of Acquired Immune Deficiency Syndromes (1999). 47: 449-58. PMID 18197121 DOI: 10.1097/Qai.0B013E3181642244 |
0.303 |
|
| 2008 |
Marinelli-Casey P, Gonzales R, Hillhouse M, Ang A, Zweben J, Cohen J, Hora PF, Rawson RA. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes. Journal of Substance Abuse Treatment. 34: 242-8. PMID 17596903 DOI: 10.1016/J.Jsat.2007.04.005 |
0.32 |
|
| 2008 |
Messina NP, Marinelli-Casey P, Hillhouse M, Ang A, Hunter J, Rawson R. Childhood Adverse Events and Health Outcomes Among Methamphetamine-Dependent Men and Women International Journal of Mental Health and Addiction. 6: 522-536. DOI: 10.1007/S11469-008-9154-4 |
0.312 |
|
| 2007 |
Rawson RA, Gonzales R, Marinelli-Casey P, Ang A. Methamphetamine dependence: a closer look at treatment response and clinical characteristics associated with route of administration in outpatient treatment. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 16: 291-9. PMID 17661197 DOI: 10.1080/10550490701389864 |
0.335 |
|
| 2007 |
Hillhouse MP, Marinelli-Casey P, Gonzales R, Ang A, Rawson RA, Anglin MD, Balabis J, Bradway R, Brown AH, Burke C, Christian D, Cohen J, Cosmineanu F, Dickow A, Donaldson M, et al. Predicting in-treatment performance and post-treatment outcomes in methamphetamine users Addiction. 102: 84-95. PMID 17493057 DOI: 10.1111/J.1360-0443.2007.01768.X |
0.34 |
|
| Show low-probability matches. |